Cargando…

Integrated analysis of EGFR mutated non‐small cell lung cancer reveals two distinct molecular subtypes

Detalles Bibliográficos
Autores principales:	Bai, Menglin, Wu, Leilei, Zhao, Mengyu, Jin, Peng, Liu, Jingru, Wang, Weiqing, Gao, Xuetian, Wang, Yanan, Chong, Wei, Yu, Jinming, Chen, Hao, Meng, Xue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Letter to the Journal
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570769/ https://www.ncbi.nlm.nih.gov/pubmed/37830123 http://dx.doi.org/10.1002/ctm2.1431

Ejemplares similares

Efficacy of Immune Checkpoint Inhibitors in Patients With EGFR Mutated NSCLC and Potential Risk Factors Associated With Prognosis: A Single Institution Experience
por: Bai, Menglin, et al.
Publicado: (2022)

Negative Correlation Between (18)F-RGD Uptake via PET and Tumoral PD-L1 Expression in Non-Small Cell Lung Cancer
por: Wu, Leilei, et al.
Publicado: (2022)

EGFR and KRAS Mutations in Lung Parenchyma of Subjects With EGFR/KRAS Wild-Type Lung Adenocarcinoma
por: Chalela, Roberto, et al.
Publicado: (2021)

Identification and validation of GABA‐driven subtypes and prognosis signature of lung adenocarcinoma
por: Li, Lifeng, et al.
Publicado: (2023)

Development of EGFR TKIs and Options to Manage Resistance of Third-Generation EGFR TKI Osimertinib: Conventional Ways and Immune Checkpoint Inhibitors
por: Wu, Leilei, et al.
Publicado: (2020)

Mutation Spectrum of EGFR From 21,324 Chinese Patients With Non-Small Cell Lung Cancer (NSCLC) Successfully Tested by Multiple Methods in a CAP-Accredited Laboratory
por: Mao, Linlin, et al.
Publicado: (2021)

Predictive value of DOT1L mutations for clinical outcomes in non‐small‐cell lung cancer patients receiving immune checkpoint inhibitor therapy
por: Guo, Tianxing, et al.
Publicado: (2023)

Cerebral amyloid angiopathy: subtypes, treatment and role in cognitive impairment
por: McLauchlan, D., et al.
Publicado: (2017)

Comprehensive profiling of EGFR mutation subtypes reveals genomic-clinical associations in non-small-cell lung cancer patients on first-generation EGFR inhibitors
por: Bai, Yongkang, et al.
Publicado: (2023)

Radiation combined with immune checkpoint inhibitors for unresectable locally advanced non-small cell lung cancer: synergistic mechanisms, current state, challenges, and orientations
por: Wu, Leilei, et al.
Publicado: (2023)

Transcriptional profiling of molecular pathways allows for the definition of robust lung squamous cell carcinoma molecular subtypes with specific vulnerabilities
por: Hijazo‐Pechero, Sara, et al.
Publicado: (2023)

Complex EGFR mutations in non-small cell lung cancer: a distinct entity?
por: Bieńkowski, Michał, et al.
Publicado: (2022)

Heterogeneity in lung cancers by single‐cell DNA sequencing
por: Zhang, Li, et al.
Publicado: (2023)

Cellular Senescence: The Villain of Metabolic Disease?: Discovery of a distinct senescent cell population in obesity-induced metabolic dysfunction
por: Lee, Gung
Publicado: (2022)

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
por: Hastings, K, et al.
Publicado: (2019)

Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis
por: Wang, Huan, et al.
Publicado: (2014)

No Overall Survival Difference in the Immunotherapy Era for Rare Subtypes of Melanoma
por: Safi, Mohammed, et al.
Publicado: (2021)

Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma
por: Yan, Junya, et al.
Publicado: (2023)

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC
por: Ju, Jia-Shiuan, et al.
Publicado: (2023)

Upregulation of Defensins in Burn Sheep Small Intestine
por: Poindexter, Brian J., et al.
Publicado: (2009)

Different subtypes of EGFR exon19 mutation can affect prognosis of patients with non-small cell lung adenocarcinoma
por: Tian, Yingying, et al.
Publicado: (2018)

Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer
por: Ali, Azhar, et al.
Publicado: (2018)

Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes
por: Liu, Si-Yang, et al.
Publicado: (2021)

Small incision cataract surgery: Review of journal abstracts
por: Sinha, Rajesh, et al.
Publicado: (2009)

Erratum to: Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis
por: Wang, Huan, et al.
Publicado: (2014)

Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients
por: Hsu, Kuo-Hsuan, et al.
Publicado: (2016)

Distinct clinical and prognostic implication of IDH1/2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic cholangiocarcinoma
por: Ma, Bingqi, et al.
Publicado: (2020)

Looseness of the Teeth
Publicado: (1842)

A Dissertation on the Diseases of the Maxillary Sinuses
por: Thackston, W. W. H.
Publicado: (1842)

A Treatise on Mechanical Dentistry: Chapter III. Of the Insertion of Entire Sets of Artificial Teeth, Both Upper and Lower, on Plates of Gold, Without Clasps or Springs
por: Brown, Solyman
Publicado: (1842)

Description of a Case of Alveolar Abscess
por: Greenwood, Isaac I.
Publicado: (1842)

The Use of Arsenious Acid for Destroying the Nerve in Decayed Teeth
por: Ide, W. E.
Publicado: (1842)

Removal of the Superior Maxillary Bone
Publicado: (1842)

Of Conjoined Suppuration of the Gums and Alveoli
por: Hayden, H. H.
Publicado: (1842)

A Treatise on Mechanical Dentistry: Chapter II: Of the Insertion of Several Teeth on Natural Roots, in Cases where the Number of Natural Roots Does Not Equal the Number of Teeth to be Inserted
por: Brown, Solyman
Publicado: (1842)

Observations on Muco-Purulent Secretion of the Antrum Maxillare
por: Hullihen, S. P.
Publicado: (1842)

On the Vascularity of Dental Bone
por: Harris, Chapin A.
Publicado: (1842)

Operation for Correcting Protrusion of the under Jaw
Publicado: (1844)

Address
por: Taylor, James
Publicado: (1844)

Opening Address
por: Taylor, Jas.
Publicado: (1844)

Cannot write session to /tmp/vufind_sessions/sess_re69fc8e1rcjq9etgeapc4s3d1